EUR 1.84
(-13.21%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 3.4 Million | 3.22 Million | 2.38 Million | 1.83 Million | 1.61 Million |
Net Income | 7.04 Million | 2.25 Million | 1.31 Million | 499.91 Thousand | 414.64 Thousand |
Depreciation & Amortization | 1.7 Million | 1.61 Million | 1.19 Million | 915.7 Thousand | 808.94 Thousand |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | - | - | - | - | - |
Other non-cash items | -7.04 Million | -2.25 Million | -1.31 Million | -499.91 Thousand | -414.64 Thousand |
Investing Cash Flow | - | - | - | - | - |
Investments in PPE | - | - | - | - | - |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |
Debt repayment | - | - | - | - | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - |
Accounts receivables | - | - | - | - | - |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | - | - | - | - | - |
Cash at beginning of period | 2.35 Million | 1.47 Million | 3.41 Million | 1.04 Million | 665.88 Thousand |
Cash at end of period | 7.2 Million | 2.35 Million | 1.47 Million | 3.41 Million | 1.04 Million |
Capital Expenditure | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | 4.84 Million | 880.47 Thousand | -1.94 Million | 2.37 Million | 381.71 Thousand |
Free Cash Flow | 3.4 Million | 3.22 Million | 2.38 Million | 1.83 Million | 1.61 Million |
Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - |
Net Income | 7.04 Million | 2.25 Million | 1.31 Million | 499.91 Thousand | 414.64 Thousand |
Depreciation & Amortization | 1.7 Million | 1.61 Million | 1.19 Million | 915.7 Thousand | 808.94 Thousand |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | - | - | - | - | - |
Other non-cash items | -7.04 Million | -2.25 Million | -1.31 Million | -499.91 Thousand | -414.64 Thousand |
Investing Cash Flow | - | - | - | - | - |
Investments in PPE | - | - | - | - | - |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |
Debt repayment | - | - | - | - | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - |
Accounts receivables | - | - | - | - | - |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | - | - | - | - | - |
Cash at beginning of period | 2.35 Million | 1.47 Million | 3.41 Million | 1.04 Million | 665.88 Thousand |
Cash at end of period | 7.2 Million | 2.35 Million | 1.47 Million | 3.41 Million | 1.04 Million |
Capital Expenditure | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | 4.84 Million | 880.47 Thousand | -1.94 Million | 2.37 Million | 381.71 Thousand |
Free Cash Flow | 3.4 Million | 3.22 Million | 2.38 Million | 1.83 Million | 1.61 Million |
603690
0NHS
002600
002349
ABNX
FHB